Houlihan Lokey, Inc. logo HLI - Houlihan Lokey, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 9
HOLD 5
SELL 1
STRONG
SELL
0
| PRICE TARGET: $188.00 DETAILS
HIGH: $211.00
LOW: $160.00
MEDIAN: $193.00
CONSENSUS: $188.00
UPSIDE: 23.99%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 85% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Fair Value Mild
Trading 5.5% below fair value
Current Price $151.63
Bear Case $112.34 25.9% downside ($112.34 - $151.63) / $151.63 = -25.9% ROTCE 20.0% → 2.75x TBV
Fair Value $160.49 5.8% upside ($160.49 - $151.63) / $151.63 = 5.8% ROTCE 25.0% → 4.00x TBV
Bull Case $208.64 37.6% upside ($208.64 - $151.63) / $151.63 = 37.6% ROTCE 30.0% → 4.00x TBV

Adjust Assumptions

57.3%
9.8%

Key Value Driver

ROTCE (57.3%) vs. cost of equity (9.8%)

Implied Market Multiple 14.19x

Plain-Language Summary

Our base-case estimate uses P/Tangible Book × ROE Quality. We then blend that result with the average analyst price target of $188.00 from 15 analysts, using a 25% weight on analyst consensus. That produces an estimated intrinsic value of $160.49 per share.

Warnings

Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.
Dividend-based valuation: $81.81 (46% below our primary estimate). Large gaps suggest the dividend may not fully reflect the company's value.

Key Risks

  • Book value quality matters as much as level — check loan loss reserves
  • Interest rate sensitivity creates non-linear earnings surprises
  • Insurance reserving is actuarial, not financial — errors emerge slowly